RecruitingNCT06591039

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

A Multicenter Prospective Observational Cohort Study of Breast Cancer Based on a Breast Cancer Medical Record Database in China


Sponsor

Fudan University

Enrollment

20,000 participants

Start Date

Jul 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment. 2. To evaluate the diagnosis and treatment and prognosis of breast cancer among patients in different regions and hospitals.


Eligibility

Inclusion Criteria1

  • Patients with malignant breast tumors must be diagnosed by cytology or histology, and their pathological types include but are not limited to breast carcinoma in situ, invasive carcinoma, and breast sarcoma.

Exclusion Criteria1

  • None

Interventions

PROCEDUREThe study did not involve intervention in the patient's treatment regimen

This study is based on a prospective database platform to register the occurrence, treatment and prognosis of breast cancer in China, so there is no clear exposure factor. This study was a prospective cohort study, which did not intervene in exposure factors, but only assessed the occurrence, treatment, and prognosis of breast cancer in China.


Locations(1)

Cancer Hospital/ Institute, Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06591039


Related Trials